Protective Effect of EECP Against Negative Inflammatory Response and Organ Dysfunction After Cardiovascular Surgery

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 400 participants.

Also called NCT06728605

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 400 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06728605
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT06728605. Randomized; quadruple masking; primary purpose prevention. Start 2025-12-31 (anticipated); primary completion 2025-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Protective Effect of EECP Against Negative Inflammatory Response and Organ Dysfunction After Cardiovascular Surgery
Acronym
PANDA
Condition
Coronary Heart Disease (CHD)
Condition
Cardio-pulmonary Bypass
Condition
Congestive Heart Failure Chronic
Condition
Cardiogenic Shock Acute
Intervention (Device)
Enhanced External Counterpulsation (EECP)
Intervention (Device)
Sham Comparator
Lead sponsor
Nanjing Medical University (class: other)
Collaborator
The First Affiliated Hospital with Nanjing Medical University (class: other)

Record details

Record id
cardio:ct-nct06728605
Content hash
83db27047bd58b65717583b82b8d394d834ba18614c7e2ce3c7892aa8b714f3c